Loading insider details...
Beta
Latest Form 4 (Jul 8, 2026): Sale of 600 NGNE shares, $21.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 8, 2026 | Neurogene Inc. (NGNE) | Sale | 600 | $21.6K |
| Jul 2, 2026 | Neurogene Inc. (NGNE) | Sale | 739 | $25.2K |
| May 8, 2026 | Neurogene Inc. (NGNE) | Sale | 4,800 | $144.4K |
| Mar 30, 2026 | Neurogene Inc. (NGNE) | Sale | 2,558 | $55.3K |
| Mar 17, 2026 | Neurogene Inc. (NGNE) | Sale | 2,387 | $48.7K |
| Mar 3, 2026 | Neurogene Inc. (NGNE) | Sale | 4,800 | $120.5K |
| Feb 24, 2026 | Neurogene Inc. (NGNE) | Grant/Award | 22,000 | n/a |
| Mar 29, 2025 | Neurogene Inc. (NGNE) | Grant/Award | 20,300 | n/a |
| Mar 17, 2025 | Neurogene Inc. (NGNE) | Sale | 4,501 | $76.2K |
| Nov 26, 2024 | Neurogene Inc. (NGNE) | Purchase | 24,000 | $491.4K |